Nielsen Fiona Cleland
Known title: DirectorCIK: 0002025277
Associated companies
Transaction History
| SLGN | ▲ Buy | Grant | 3,254 | — | 5/27/2026 | View on chart |
| SLGN | ▲ Buy | Grant | 2,262 | — | 5/28/2025 | View on chart |
| SLGN | ▲ Buy | Grant | 2,712 | — | 5/29/2024 | View on chart |
| SLGN | ▲ Buy | Grant | 3,254 | — | 5/27/2026 | View on chart |
| SLGN | ▲ Buy | Grant | 2,262 | — | 5/28/2025 | View on chart |
| SLGN | ▲ Buy | Grant | 2,712 | — | 5/29/2024 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
UBS Cuts Silgan Price Target to $38, Maintains Neutral Rating
UBS lowered its price target for Silgan Holdings to $38 while keeping a neutral stance. This move places the bank's outlook near the bottom of the current analyst range, which extends up to $61. The stock is currently trading below its 52-week high, reflecting broader market caution.
UBS Cuts Silgan Price Target to $38, Maintains Neutral Rating. UBS lowered its price target for Silgan Holdings to $38 while keeping a neutral stance. This move places the bank's outlook near the bottom of the current analyst range, which extends up to $61. The stock is currently trading below its 52-week high, reflecting broader market caution.